2022 SCSG Liver Symposium

The Southern California Society of Gastroenterology (SCSG) is pleased to announce the hybrid 2022 Liver Symposium being held December 17–18, 2022, both online and in-person at The Ritz Carlton, Laguna Niguel in Dana Point, CA.

​

The symposium will provide a unique opportunity to receive a comprehensive update in chronic liver disease from nationally renowned faculty. The educational lectures at this symposium will focus on important advances presented at the annual American Association for the Study of Liver Disease (AASLD) Meeting and/or in recent publications. You will also have ample opportunity to interact with colleagues, our expert faculty members, and industry representatives.

For questions or inquiries, please contact the SCSG via email at scsg@pacemedcom.com.

​

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease (CLD).

Statement of Need

The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease.

Educational Objectives

Upon completion of this symposium, participants should be better able to:

• Describe new data as it pertains to the implications and options for patients as it pertains to their continued care
• Apply updated guidelines for care for chronic liver and GI related diseases
• Discuss future directions of therapeutics, diagnostics, and technology in the management of GI and liver diseases

​

Sincerely,​

The Liver Symposium Co-Chair Committee

Steven-Huy Han, MD

Paul Pockros, MD

Jeffrey Kahn, MD

This activity is supported by educational grants from Salix Pharmaceuticals, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Mallinckrodt Pharmaceuticals.

Jointly provided by the Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Southern California Society of Gastroenterology (SCSG).